Pons, M. Et Al. 2023. Do Long-term Patient-reported Outcomes Improve Similarly in Psoriatic Arthritis and Axial Spondyloarthritis Patients Treated with Secukinumab? Results from the EuroSpA Collaboration. ARTHRITIS & RHEUMATOLOGY , 2779-2782.

Pons, M., Rasmussen, S. H., Christiansen, S. N., Michelsen, B., Glintborg, B., Gudbjornsson, B., ... Grondal, G. M.(2023). Do Long-term Patient-reported Outcomes Improve Similarly in Psoriatic Arthritis and Axial Spondyloarthritis Patients Treated with Secukinumab? Results from the EuroSpA Collaboration. ARTHRITIS & RHEUMATOLOGY , 2779-2782.

Pons, Marion Et Al. "Do Long-term Patient-reported Outcomes Improve Similarly in Psoriatic Arthritis and Axial Spondyloarthritis Patients Treated with Secukinumab? Results from the EuroSpA Collaboration," ARTHRITIS & RHEUMATOLOGY , 2779-2782, 2023

Pons, Marion Et Al. "Do Long-term Patient-reported Outcomes Improve Similarly in Psoriatic Arthritis and Axial Spondyloarthritis Patients Treated with Secukinumab? Results from the EuroSpA Collaboration." ARTHRITIS & RHEUMATOLOGY , pp.2779-2782, 2023

Pons, M. Et Al. (2023) . "Do Long-term Patient-reported Outcomes Improve Similarly in Psoriatic Arthritis and Axial Spondyloarthritis Patients Treated with Secukinumab? Results from the EuroSpA Collaboration." ARTHRITIS & RHEUMATOLOGY , pp.2779-2782.

@article{article, author={Marion Pons Et Al. }, title={Do Long-term Patient-reported Outcomes Improve Similarly in Psoriatic Arthritis and Axial Spondyloarthritis Patients Treated with Secukinumab? Results from the EuroSpA Collaboration}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2023, pages={2779-2782} }